Renaissance Technologies’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.4K | Buy |
85,399
+71,100
| +497% | +$29.5K | ﹤0.01% | 3427 |
|
|
2025
Q1 | $8.91K | Buy |
+14,299
| New | +$8.91K | ﹤0.01% | 3394 |
|
|
2024
Q4 | – | Sell |
-155,300
| Closed | -$283K | – | 3547 |
|
|
2024
Q3 | $283K | Sell |
155,300
-282,900
| -65% | -$515K | ﹤0.01% | 3002 |
|
|
2024
Q2 | $2.64M | Buy |
438,200
+204,100
| +87% | +$1.23M | ﹤0.01% | 1699 |
|
|
2024
Q1 | $2.61M | Sell |
234,100
-36,400
| -13% | -$406K | ﹤0.01% | 1846 |
|
|
2023
Q4 | $4.03M | Buy |
270,500
+58,000
| +27% | +$864K | 0.01% | 1487 |
|
|
2023
Q3 | $1.02M | Buy |
212,500
+29,700
| +16% | +$143K | ﹤0.01% | 2277 |
|
|
2023
Q2 | $1.37M | Buy |
182,800
+55,981
| +44% | +$420K | ﹤0.01% | 2247 |
|
|
2023
Q1 | $573K | Buy |
126,819
+31,019
| +32% | +$140K | ﹤0.01% | 2809 |
|
|
2022
Q4 | $1.08M | Sell |
95,800
-74,800
| -44% | -$843K | ﹤0.01% | 2486 |
|
|
2022
Q3 | $1.63M | Sell |
170,600
-57,083
| -25% | -$546K | ﹤0.01% | 2160 |
|
|
2022
Q2 | $1.84M | Buy |
227,683
+78,883
| +53% | +$638K | ﹤0.01% | 2244 |
|
|
2022
Q1 | $2.52M | Sell |
148,800
-19,100
| -11% | -$323K | ﹤0.01% | 2059 |
|
|
2021
Q4 | $3.61M | Buy |
+167,900
| New | +$3.61M | ﹤0.01% | 1733 |
|